Approach to metabolic acidosis: Clinical sciences

Last updated: January 05, 2026

Approach to metabolic acidosis: Clinical sciences

Block 3 CVH

Block 3 CVH

Angina pectoris
Stable angina
Ludwig angina
Unstable angina
Prinzmetal angina
Heart failure
Heart failure: Pathology review
Stroke volume, ejection fraction, and cardiac output
Congestive heart failure: Clinical sciences
Dilated cardiomyopathy
Restrictive cardiomyopathy
Frank-Starling relationship
Myocardial infarction
Acute coronary syndrome: Clinical sciences
ECG cardiac infarction and ischemia
Loop diuretics
Thiazide and thiazide-like diuretics
Potassium sparing diuretics
cGMP mediated smooth muscle vasodilators
ACE inhibitors, ARBs and direct renin inhibitors
Positive inotropic medications
Coronary artery disease: Clinical sciences
Adrenergic antagonists: Beta blockers
Calcium channel blockers
Coronary artery disease: Pathology review
Hereditary spherocytosis
Intrinsic hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Approach to anemia (destruction and sequestration): Clinical sciences
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Pyruvate kinase deficiency
Paroxysmal nocturnal hemoglobinuria
Warm autoimmune hemolytic anemia and cold agglutinin (NORD)
Lead poisoning
Oxygen-hemoglobin dissociation curve
Sickle cell disease (NORD)
Sickle cell disease: Clinical sciences
Beta-thalassemia
Beta-thalassemia: Year of the Zebra
Alpha-thalassemia
Mitral valve disease
Valvular heart disease: Pathology review
Valvular insufficiency (regurgitation): Clinical sciences
Abnormal heart sounds
Aortic stenosis: Clinical sciences
Aortic valve disease
Infectious endocarditis: Clinical sciences
Acute rheumatic fever and rheumatic heart disease: Clinical sciences
Rheumatic heart disease
Tricuspid valve disease
Pulmonary valve disease
Persistent truncus arteriosus
Transposition of the great vessels
Approach to congenital heart diseases (cyanotic): Clinical sciences
Tetralogy of Fallot
Tetralogy of Fallot: Year of the Zebra
Total anomalous pulmonary venous return
Ventricular septal defect
Approach to congenital heart diseases (acyanotic): Clinical sciences
Atrial septal defect
Patent ductus arteriosus
Acyanotic congenital heart defects: Pathology review
Coarctation of the aorta
Cardiac tumors
Cardiac and vascular tumors: Pathology review
Carcinoid syndrome
Hypertension: Pathology review
Hypertension
Hypertensive emergency
Pulmonary hypertension
Essential hypertension: Clinical sciences
Pulmonary hypertension: Clinical sciences
Approach to hypertension: Clinical sciences
Cor pulmonale
Pulmonary arterial hypertension (NORD)
Cardiomyopathies: Pathology review
Hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy: Clinical sciences
Cardiac conduction velocity
Cardiac conduction system
ECG cardiac hypertrophy and enlargement
ECG axis
ECG intervals
ECG basics
ECG QRS transition
ECG rate and rhythm
ECG normal sinus rhythm
Atrial fibrillation
Supraventricular arrhythmias: Pathology review
Atrial flutter
Ventricular fibrillation
Ventricular arrhythmias: Pathology review
Atrioventricular block: Clinical sciences
Atrioventricular block
Heart blocks: Pathology review
Long QT syndrome and Torsade de pointes
Brugada syndrome
Pericarditis and pericardial effusion
Pericarditis: Clinical sciences
Recurrent pericarditis (NORD)
Pericardial disease: Pathology review
Cardiac tamponade: Clinical sciences
Myocarditis
Shock
Approach to shock: Clinical sciences
Shock: Pathology review
Iron deficiency and iron deficiency anemia (pediatrics): Clinical sciences
Iron deficiency anemia
Iron deficiency anemia: Clinical sciences
Anemia of chronic disease: Year of the Zebra
Anemia of chronic disease
Folate (Vitamin B9) deficiency
Anemia in pregnancy: Clinical sciences
Vitamin B12 deficiency
Vitamin B12 deficiency: Clinical sciences
Orotic aciduria
Diamond-Blackfan anemia
Sideroblastic anemia
Approach to anemia in the newborn and infant (underproduction): Clinical sciences
Acute intermittent porphyria
Porphyria cutanea tarda
Aplastic anemia
Non-hemolytic normocytic anemia: Pathology review
Fanconi anemia
Megaloblastic anemia
Macrocytic anemia: Pathology review
Autoimmune hemolytic anemia
Microcytic anemia: Pathology review
Pernicious anemia: Year of the Zebra
Approach to anemia in the newborn and infant (destruction and blood loss): Clinical sciences
Approach to anemia (underproduction): Clinical sciences
Epstein-Barr virus (Infectious mononucleosis)
Bartonella henselae (Cat-scratch disease and Bacillary angiomatosis)
Acute leukemia
Approach to leukemia: Clinical sciences
Leukemias: Pathology review
Approach to myeloproliferative neoplasms: Clinical sciences
Chronic leukemia
Myeloproliferative disorders: Pathology review
Non-Hodgkin lymphoma
Lymphomas: Pathology review
Approach to lymphoma: Clinical sciences
Hodgkin lymphoma
Multiple myeloma: Clinical sciences
Multiple myeloma
Waldenstrom macroglobulinemia
Plasma cell disorders: Pathology review
Amyloidosis
Monoclonal gammopathy of undetermined significance
Myelodysplastic syndromes
Approach to myelodysplastic syndromes: Clinical sciences
Polycythemia vera (NORD)
Essential thrombocythemia (NORD)
Myelofibrosis (NORD)
Mastocytosis (NORD)
Langerhans cell histiocytosis
Langerhans cell histiocytosis: Year of the Zebra
Non-steroidal anti-inflammatory drugs
Antiplatelet medications
Anticoagulants: Direct factor inhibitors
Thrombolytics
Anticoagulants: Heparin
Heparin-induced thrombocytopenia
Anticoagulants: Warfarin
Osmotic diuretics
Sympatholytics: Alpha-2 agonists
Sympathomimetics: Direct agonists
Wiskott-Aldrich syndrome
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Premature ventricular contraction
Supraventricular tachycardia: Clinical sciences
Wolff-Parkinson-White syndrome
Anatomy clinical correlates: Heart
Approach to bradycardia: Clinical sciences
Premature atrial contraction
Bundle branch block
Approach to a murmur (pediatrics): Clinical sciences
Approach to cyanosis (newborn): Clinical sciences
Cyanotic congenital heart defects: Pathology review
Williams syndrome
Hypoplastic left heart syndrome
Hypoplastic left heart syndrome: Year of the Zebra 2024
Kawasaki disease
Kawasaki disease: Clinical sciences
Approach to chest pain: Clinical sciences
Ventricular tachycardia: Clinical sciences
Approach to syncope: Clinical sciences
Approach to tachycardia: Clinical sciences
Atrioventricular nodal reentrant tachycardia (AVNRT)
Approach to acid-base disorders: Clinical sciences
Acid-base map and compensatory mechanisms
The role of the kidney in acid-base balance
Acid-base disturbances: Pathology review
Plasma anion gap
Approach to metabolic acidosis: Clinical sciences
Metabolic acidosis
Metabolic alkalosis
Respiratory alkalosis
Approach to metabolic alkalosis: Clinical sciences
Approach to respiratory alkalosis: Clinical sciences
Renal tubular acidosis
Respiratory acidosis
Approach to respiratory acidosis: Clinical sciences
Neuroblastoma
Neuroblastoma: Year of the Zebra 2024
Nephroblastoma (Wilms tumor)

Decision-Making Tree

Transcript

Watch video only

Metabolic acidosis refers to an increase in hydrogen ion concentration and a decrease in bicarbonate concentration in the blood. This can cause the pH to fall below 7.35 and serum bicarbonate level under 22 milliequivalents per liter. As a reference bicarbonates normally range from 22 to 27 miliequivalents per liter. Metabolic acidosis can be classified as either normal anion gap metabolic acidosis, which occurs in conditions like renal tubular acidosis, or elevated anion gap metabolic acidosis, which is seen in conditions like ketoacidosis.

If a patient presents with a chief concern suggesting metabolic acidosis, first perform an ABCDE assessment to determine if they are unstable.

If your patient is unstable, stabilize their airway, breathing, and circulation. Next, obtain IV access, put your patient on continuous vital sign monitoring, and provide supplemental oxygen, if needed. Here’s a clinical pearl! Severe cases might present with nausea, vomiting, lethargy, and tachypnea; and might need treatment with hemodialysis.

Let’s move on to stable patients. First, obtain a focused history and physical exam and order labs, including an arterial blood gas analysis or ABG, and CMP.

Patients may report diarrhea and vomiting, or they may have a history of diabetes mellitus. The physical exam might reveal signs of dehydration, such as dry oral mucous membranes and decreased skin turgor, and there might be an increased respiratory rate as the body tries to compensate for the acidosis.

If the ABG shows an arterial pH below 7.35 and the CMP shows decreased serum bicarbonate, typically below 22 milliequivalents per liter, that’s metabolic acidosis.

Here’s a clinical pearl! In metabolic acidosis, the body tries to compensate by increasing the rate and depth of breathing, which eliminates CO2 and lowers the pCO2.

To assess if the compensation is adequate, use the Winter formula: the range of expected pCO2 is equal to 1.5 times the bicarbonate level, plus 8, and plus or minus 2. If the measured pCO2 falls within this calculated range, the respiratory compensation is adequate. On the flip side, if the measured pCO2 is higher than calculated, there might be both metabolic and respiratory acidosis occurring at the same time.

Lastly, if the measured pCO2 is lower than calculated, your patient might be having concurrent metabolic acidosis and respiratory alkalosis.

Now that you know your patient has metabolic acidosis, your next step is to calculate the anion gap. The normal anion gap is due to the difference between unmeasured anions like sulfate, phosphate, albumin, and organic anions and cations such as potassium, magnesium, and calcium. Therefore, fluctuations in these unmeasured anions and cations may influence the anion gap. To calculate use this formula: serum sodium minus the sum of the serum chloride and bicarbonate.

Okay, let’s go over a normal anion gap range. A normal anion gap ranges from 4 to 12 milliequivalents per liter. If your patient has a normal anion gap, look for the specific cause. To remember the causes of normal anion gap metabolic acidosis, use the mnemonic HARDUPS. H stands for hyperalimentation, which is the delivery of nutrients into the vein, hypoadrenalism and hypoaldosteronism; A for acetazolamide, R for renal tubular acidosis, D for diarrhea, U for ureterostomies, P for post-hypocapnic state, and finally, S stands for spironolactone as well as saline infusion.

Okay, let’s first go over iatrogenic causes, referring to hyperalimentation, saline infusion, and acetazolamide. In such cases, patients might have a recent history of receiving total parenteral nutrition or TPN, or infusion of a large volume of IV normal saline When amino acids in TPN are metabolized, a lot of hydrogen ions are released which decreases the pH. Next, saline in large amounts can dilute the serum bicarbonate concentration and disrupt the body's acid-base balance due to excess chloride administered relative to sodium. Additionally, they might report taking medications, such as carbonic anhydrase inhibitors, like acetazolamide, or potassium-sparing diuretics, like amiloride. If this is the case, your patient’s metabolic acidosis is due to iatrogenic causes.

Moving on to renal tubular acidosis, which causes metabolic acidosis due to either impairment of hydrogen secretion like in types 1 and 4 or bicarbonate absorption like in type 2.

These patients often report muscle weakness, and possibly a history of recurrent urinary tract infections and kidney stones. Their CMP may show slightly elevated BUN and creatinine.
With these findings, consider renal tubular acidosis, and calculate the eGFR.
Normal eGFR, meaning above 60 milliliters per minute, confirms your diagnosis of renal tubular acidosis.

Next up is gastrointestinal loss of bicarbonate through diarrhea. Patients typically report profuse diarrhea, while the physical exam may show signs of dehydration, like dry mucous membranes or decreased skin turgor. Additionally, CMP reveals decreased sodium and potassium levels. If you see these findings, the patient’s metabolic acidosis is due to gastrointestinal loss of bicarbonate.

Let's go over an elevated anion gap range. Let’s start with methanol and ethylene glycol toxicity.

Alright, let’s take a step back to the anion gap, and have a look at individuals with an anion gap of more than 12 milliequivalents per liter. In this case, your patient has an elevated anion gap metabolic acidosis. To remember the causes, use a mnemonic GOLD MARK. G stands for glycols, O for oxoproline, L for L-lactate, D for D-lactate, M for methanol, A for aspirin, R for renal failure, and lastly, K stands for ketoacidosis.

Sources

  1. "Diabetic ketoacidosis: role of the kidney in the acid-base homeostasis re-evaluated." Kidney Int. (1984;25(4):591-598. )
  2. "Renal Tubular Acidosis. Indian" J Pediatr. (2020;87(9):733-744. )
  3. "Acute iron poisoning: management guidelines. " Indian Pediatr (2003;40(6):534-540. )
  4. "Stewart and beyond: new models of acid-base balance. " Kidney Int. (2003;64(3):777-787. )
  5. "Joint British Diabetes Societies for Inpatient Care. The management of diabetic ketoacidosis in adults-An updated guideline from the Joint British Diabetes Society for Inpatient Care. " Diabet Med. (2022;39(6):e14788. )
  6. "Disorders associated with an altered anion gap. " Kidney Int. (1985;27(2):472-483. )
  7. "The Diagnosis and Management of Toxic Alcohol Poisoning in the Emergency Department: A Review Article. " Adv J Emerg Med. (2019;3(3):e28. Published 2019 May 22. )
  8. "Dilution acidosis and contraction alkalosis: review of a concept. " Kidney Int. (1975;8(5):279-283. )
  9. "Metabolic Acidosis in Chronic Kidney Disease: Pathogenesis, Clinical Consequences, and Treatment. " Electrolyte Blood Press. (2021;19(2):29-37. )
  10. "Serum anion gap: its uses and limitations in clinical medicine. " Clin J Am Soc Nephrol. (2007;2(1):162-174. )
  11. "Acid-Base Basics [published correction appears in " Semin Nephrol. (2019 Sep;39(5):515].)
  12. "KDIGO. Clinical Practice Guideline for Acute Kidney Injury." Kdigo.org. (2012)
  13. "Salicylate poisoning: an evidence-based consensus guideline for out-of-hospital management.;45(2):95-131." Clin Toxicol (Phila) (2007)
  14. "Ethylene glycol exposure: an evidence-based consensus guideline for out-of-hospital management.;43(5):327-345." Clin Toxicol (Phila) (2005)